Amgen

Open: 304.73 Close: 307.81 Change: 3.08

The unbelievably easy way to evaluate Amgen Company Inc Stock: Use an AI.

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Inc, share, compare, last, USPTO, job, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen shares of Amgen Inc. reachead $307.81 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close. Amgen recorded free cash flow worth a fulsome 91% of its EBIT in the last three years.

Today's News

Amgen shares of Amgen Inc. reachead $307.81 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close. Amgen has built a huge osteoporosis franchise that also includes Xvega and Evenity. USPTO issued “ Guidelines for Assessing Enablement in Utility Applications and Patents in view of the Supreme Court Decision in Amgen Inc. Amgen finance manager - thailand jobs at amgen in bangkok.com Apply now for a career that defies imagination. Amgen has about 18 drugs that could be billion-dollar formulations. CEO Bob Bradway is excited about what he has seen for artificial intelligence. Amgen (NASDAQ:AMGN) can stay on top of its debt. Amgen recorded free cash flow worth a fulsome 91% of its EBIT in the last three years. The company had liabilities of US$17.0b due within 12 months, and liabilities of $65.9b due beyond that. This is Amgens third round of layoffs this year. The company plans to cut its CEOs salary by 40% in an effort to save cash. More than 80% of Horizons staff will be absorbed into Amgen roles. Amgen Inc. principal is business system analyst – r&d jobs at amgen in united states - remote.com Amgen is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran. Amgen stock opened at $302.25 on Friday 01/19/2024 on NAS, this is a gain of 1.81% compared to the opening price on Friday. Amgen Inc.s market capitalization is $162.83 B by 535.18 M shares. USPTO Provides Guidance in light of Amgen v. Sanofi v. 23 decision in Amgen, Inc. decision. Amgen is focusing its endeavours on innovation within the obesity space, where it currently has two therapies in the pipeline. Amgen presented at JP Morgans 42nd Annual Healthcare Conference 2024.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Inc, share, compare, last, USPTO, job, and the most common words in the summary are: amgen, development, stock, market, best, inc, news, . One of the sentences in the summary was: Amgen shares of Amgen Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #development #stock #market #best #inc #news.